James Patrick Kelly

James Patrick Kelly is a declared insider at 2 companies; the most frequent names are Vanda Pharmaceuticals Inc. and Novavax Inc. We count 50 filings; the first trade dates from 4 January 2016 and the latest from 7 March 2026.

The open-market record consists of 12 sales worth €1.1M, with no purchase. Besides market trades, the filings include 15 share grants and 23 option exercises.

The record was last updated on 9 March 2026 with a share grant (€51k) in Novavax Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.